What happened
SK biopharmaceuticals disclosed a supply contract with SK Life Science,Inc., worth US$46.5M, about 9% of its recent annual revenue, running through Sep 2026.
For context, this single contract equals about 9% of the company's most recent annual revenue.
| Counterparty | SK Life Science,Inc. |
|---|---|
| Contract value | US$46.5M |
| vs. recent revenue | 9% |
| Through | Sep 2026 (from Sep 2026) |
| Filed | 2026-09-23, Supply contract signed |
| Source | DART rcept 20260923800342 → open original filing |
Source: DART. Information only, not investment advice.